Pigmented villonodular synovitis managed by total synovectomy and cementless total hip arthroplasty

  • Mohamed Mansour ElzohairyEmail author
Original Article • HIP - ARTHROPLASTY



Pigmented villonodular synovitis or PVNS is a benign proliferating disease of the synovium; it behaves much as a neoplastic process does.


This retrospective clinical study included 11 consecutive cases who underwent for total synovectomy combined with cementless total hip arthroplasty of PVNS of the hip joint.


The mean patient preoperative hip score of Harris was 46.1 points (range 30–70 points) improved to 94.3 points (range 90–100 points) at the last follow-up visits. No clinical or radiological evidence of recurrent PVNS or osteolysis or loosening had been detected in our patients.


Total synovectomy combined with total arthroplasty (THA) could be considered as the ideal treatment in the case of pigmented villonodular synovitis with major osteoarticular destruction and provided good results, as reported in the current series.

Level of evidence

IV, case series.


Pigmented villonodular synovitis Synovectomy Cementless Total hip arthroplasty 



We would like to express our sincere thanks to Habiba Elzohairy, Egypt, for her help and support during the preparation of this study.

Compliance with ethical standards

Conflict of interest

The author declares that there is no conflict of interest.


  1. 1.
    Levy DM, Haughom BD, Nho SJ, Gitelis S (2016) Pigmented villonodular synovitis of the hip: a systematic review. Am J Orthop Belle Mead NJ 45:23–28PubMedGoogle Scholar
  2. 2.
    Jaffe HL, Lichtenstein L, Sutro CJ (1941) Pigmented villonodular synovitis, bursitis and tenosynovitis. Arch Pathol 31:731–765Google Scholar
  3. 3.
    Steinmetz S, Laure Rougemont A, Peter R (2016) Pigmented villonodular synovitis of the hip. EOR 1:260–266PubMedGoogle Scholar
  4. 4.
    Mankin H, Trahan C, Hornicek F (2011) Management of pigmented villonodular synovitis in the hip: a case series. J Surg Oncol 103:386–389CrossRefPubMedGoogle Scholar
  5. 5.
    Friedman T, Chen T, Chang A (2013) MRI diagnosis of recurrent pigmented villonodular synovitis following total joint arthroplasty. HSS J 9:100–105CrossRefPubMedGoogle Scholar
  6. 6.
    Byrd JWT, Jones KS, Maiers GP (2013) Two to 10 years’ follow-up of arthroscopic management of pigmented villonodular synovitis in the hip: a case series. Arthrosc J 29:1783–1787CrossRefGoogle Scholar
  7. 7.
    Lee S, Haro MS, Riff A, Bush-Joseph CA, Nho SJ (2014) Arthroscopic technique for the treatment of pigmented villonodular synovitis of the hip. Arthrosc Tech 4:41–46CrossRefGoogle Scholar
  8. 8.
    Yoo JJ, Kwon YS, Kwon KS, Koo KH, Yoon KS, Byug WM, Kim HJ (2010) Cementless total hip arthroplasty performed in patients with pigmented villonodular synovitis. J Arthroplasty 25:552–557CrossRefPubMedGoogle Scholar
  9. 9.
    Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51:737–755CrossRefPubMedGoogle Scholar
  10. 10.
    Gitelis S, Heligman D, Morton T (1989) The treatment of pigmented villonodular synovitis of the hip. A case report and literature review. Clin Orthop Relat Res 239:154Google Scholar
  11. 11.
    Paprosky WG, Perona PG, Lawrence JM (1994) Acetabular defect classification and surgical reconstruction in revision arthroplasty: a 6-year follow-up evaluation. J Arthroplasty 9:33–44CrossRefPubMedGoogle Scholar
  12. 12.
    Paprosky WG, Lawrence J, Cameron H (1990) Femoral defect classification. Clinical application. Orthop Rev 19(suppl 9):9–17Google Scholar
  13. 13.
    Engh CA, Massin P, Suthers KE (1990) Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res 257:107Google Scholar
  14. 14.
    Joshi RP, Eftekhar NS, McMahon DJ, Nercessian OA (1997) Osteolysis after Charnley primary low-friction arthroplasty. A comparison of two matched paired groups. J Bone Joint Surg Br 80:585CrossRefGoogle Scholar
  15. 15.
    Chiari C, Pirich C, Brannath W, Kotz R, Trieb K (2006) What affects the recurrence and clinical outcome of pigmented villonodular synovitis? Clin Orthop Relat Res 450:172–178CrossRefPubMedGoogle Scholar
  16. 16.
    Park G, Kim YS, Kim JH et al (2012) Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years. Acta Orthop 83:256–260CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Vastel L, Lambert P, De Pinieux G et al (2005) Surgical treatment of pigmented villonodular synovitis of the hip. J Bone Joint Surg (Am) 87:1019–1024CrossRefGoogle Scholar
  18. 18.
    Flipo RM, Desvigne-Noulet MC, Cotten A et al (1994) La synovite villo-nodulaire pigmentée de la hanche. Résultats d’une enquête nationale à propos de 58 observations. Rev Rhum Mal Osteoartic 61:85–95Google Scholar
  19. 19.
    Gonzàlez Della Valle A, Piccaluga F, Potter HG, Salvati EA, Pusso R (2001) Pigmented villonodular synovitis of the hip: 2 to 23 year follow up study. Clin Orthop Relat Res 388:187–199CrossRefGoogle Scholar
  20. 20.
    Kumar N, Arora GN, Datta B (2014) Bearing surfaces in hip replacement—evolution and likely future. Med J Armed Forces India 70:371–376CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Descamps F, Yasik E, Hardy D, Lafontaine M, Delince P (1991) Pigmented villonodular synovitis of the hip. A case report and review of the literature. Clin Rheumatol 10:184–190CrossRefPubMedGoogle Scholar
  22. 22.
    Friesecke C, Granes R, Siemssen N (2013) Bone transplantation with total hip endoprosthesis for diffuse pigmented villonodular synovitis. Orthopade 42:884–888CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France SAS, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Zagazig UniversityZagazigEgypt
  2. 2.ZagazigEgypt

Personalised recommendations